Hostname: page-component-68945f75b7-l9cl4 Total loading time: 0 Render date: 2024-08-06T04:17:58.144Z Has data issue: false hasContentIssue false

Letters to the Editor

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Kwon, OY, Chung, SP, Ha, YR, Yoo, IS, Kim, SW.Delayed postanoxic encephalopathy after carbon monoxide poisoning. Emerg Med J. 2004;21:2501.Google Scholar
2.Wang, P, Zeng, T, Chi, ZF.Recovery of cognitive dysfunction in a case of delayed encephalopathy of carbon monoxide poisoning after treatment with donepezil hydrochloride. Neurol India. 2009;57:4812.Google Scholar
3.Lee, MS, Marsden, CD.Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov Disord. 1994;9:5508.Google Scholar
4.Gilmer, B, KIlkeny, J, Tomaszewski, C, Watts, JA.Hyperbaric oxygen dose not prevent neurologic sequalae after carbon monoxide poisoning. Acad Emerg Med. 2002;9:18.Google Scholar
5.Noh, MY, Koh, SH, Kim, Y, Kim, HY, Cho, GW, Kim, SH.Neuroprotective effects of donepezil through inhibition of GSD-3 activity in amyloid-beta-induced neuronal cell death. J Neurochem. 2009;108:111625.Google Scholar
6.Kim, SH, Park, JH, Kim, YH, Koh, SB.Stereopsis in drug naïve parkinson’s disease patients. Can J Neurol Sci. 2011;38:299302.Google Scholar
7.Biousse, V, Skibell, BC, Watts, RL, Loupe, DN, Drews-Botsch, C, Newman, NJ.Ophthalmologic features of parkinson’s disease. Neurology. 2004;62:17780.CrossRefGoogle ScholarPubMed
8.Van Noorden, GK.Binocular vison and ocular motility. St. Louis: CV Mosby; 1990. p. 196410.Google Scholar
9.Leigh, RJ, Zee, DS.The neurology of eye movements. 4th ed. New York: Oxford University Press; 2006. p. 368.Google Scholar
10.Repka, MX, Claro, MC, Loupe, DN, Reich, SG.Ocular motility in parkinson’s disease. J Pediatr Ophthalmol Strabismus. 1996;33:1447.Google Scholar
11.Racette, BA, Gokden, MS, Tychsen, LS, Perlmutter, JS.Convergence insufficiency in idiopathic parkinson’s disease responsive to levodopa. Strabismus. 1999;7:16974.Google Scholar
12.Smetana, GW, Shmerling, RH.Does this patient have temporal arteritis? JAMA. 2002; 287(1):92101.CrossRefGoogle ScholarPubMed
13.González-Gay, MA, García-Porrúa, C, Llorca, J, et al.Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Med Balt. 2000; 79(5):28392.Google Scholar
14.Rao, JK, Allen, NB, Pincus, T.Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis. Ann Intern Med. 1998; 129(5):34552.Google Scholar
15.Dasgupta, B.Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010; 10(4):3816.Google Scholar
16.Borg, FA, Salter, VL, Dasgupta, B.Neuro-ophthalmic complications in giant cell arteritis. Curr Allergy Asthma Rep. 2008; 8:32330Google Scholar
17.Roberts, EA, Schilsky, ML.Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008 Jun;47(6):2089111.Google Scholar
18.Soltanzadeh, A, Soltanzadeh, P, Nafissi, S, Ghorbani, A, Sikaroodi, H, Lotfi, J.Wilson’s disease: a great masquerader. Eur Neurol. 2007;57(2):805.Google Scholar
19.Lorincz, MT.Neurologic Wilson’s disease. Ann Ny Acad Sci. 2010;1184:17387.Google Scholar
20.Machado, A, Chien, HF, Deguti, MM, et al.Neurological manifestations in Wilson’s disease: report of 119 cases. Movement Disord. 2006 Dec;21(12):21926.Google Scholar
21.Prashanth, LK, Taly, AB, Sinha, S, Arunodaya, GR, Swamy, HS.Wilson’s disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):9079.Google Scholar